Basis: Four-quarter free cash flow / FMP quote market capitalization × 100. Source: stored company filings and market data; unavailable inputs remain N/A.
The free cash flow yield is N/A as of 2026-10-06T14:26:14.509Z.
Calculation as of: 2026-10-06T14:26:14.509Z.
Quote observation: 2026-10-06T14:25:04.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: df0d51bc4c7c4fe031789de0e9442acf829cec50a05ec95901a80cda74a8a9f3
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
FREE CASH FLOW YIELD
N/A
Enliven Therapeutics, Inc.
Market Cap
$2.99B
Free Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$3.03B
Free Cash Flow Yield
N/A
TTM Avg
9.18%
3Y Avg
9.18%
5Y Avg
9.18%
Market Cap
$3.03B
Free Cash Flow Yield
N/A
TTM Avg
6.34%
3Y Avg
5.74%
5Y Avg
5.74%
Market Cap
$3.04B
Free Cash Flow Yield
1.29%
TTM Avg
0.97%
3Y Avg
0.97%
5Y Avg
0.97%
Market Cap
$2.82B
Free Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$2.80B
Free Cash Flow Yield
2.82%
TTM Avg
3.13%
3Y Avg
2.70%
5Y Avg
2.70%
Market Cap
$2.79B
Free Cash Flow Yield
1.84%
TTM Avg
2.05%
3Y Avg
1.80%
5Y Avg
1.80%
Market Cap
$2.69B
Free Cash Flow Yield
N/A
TTM Avg
0.48%
3Y Avg
1.33%
5Y Avg
1.45%
Market Cap
$2.69B
Free Cash Flow Yield
5.89%
TTM Avg
5.78%
3Y Avg
3.95%
5Y Avg
3.33%
| NAME | MARKET CAP | FREE CASH FLOW YIELD | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Enliven Therapeutics, Inc. (ELVN) | $2.99B | N/A | N/A | N/A | N/A |
| Amylyx Pharmaceuticals, Inc. (AMLX)vs › | $3.03B | N/A | 9.18% | 9.18% | 9.18% |
| Denali Therapeutics Inc. (DNLI)vs › | $3.03B | N/A | 6.34% | 5.74% | 5.74% |
| Arcutis Biotherapeutics, Inc. (ARQT)vs › | $3.04B | 1.29% | 0.97% | 0.97% | 0.97% |
| Dyne Therapeutics, Inc. (DYN)vs › | $2.82B | N/A | N/A | N/A | N/A |
| TransMedics Group, Inc. (TMDX)vs › | $2.80B | 2.82% | 3.13% | 2.70% | 2.70% |
| AtriCure, Inc. (ATRC)vs › | $2.79B | 1.84% | 2.05% | 1.80% | 1.80% |
| Neogen Corporation (NEOG)vs › | $2.69B | N/A | 0.48% | 1.33% | 1.45% |
| Aveanna Healthcare Holdings Inc. (AVAH)vs › | $2.69B | 5.89% | 5.78% | 3.95% | 3.33% |
| MBX Biosciences, Inc. Common Stock (MBX)vs › | $2.69B | N/A | N/A | N/A | N/A |
FCF Yield
N/A
Earnings Yield
N/A
Dividend Yield
N/A
Formula: FCF Yield = (Free Cash Flow / Market Cap) × 100
How FCF Yield is used:
FCF vs earnings: Differences between FCF yield and earnings yield can reflect capital expenditures, working capital changes, and other non-cash accounting items.
FCF Yield measures free cash flow relative to market capitalization. It compares cash generation after capital expenditures with the equity value of the company.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
